BlackRock’s Edesa Biotech EDSA Stock Holding History

BlackRock’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$145K	Buy	+27,709	New	+$83.1K	﹤0.01%	4872
2024 Q1	–	Sell	-74	Closed	-$338	–	5305
2023 Q4	$338	Hold	74	–	–	﹤0.01%	5302
2023 Q3	$327	Hold	74	–	–	﹤0.01%	5368
2023 Q2	$420	Hold	74	–	–	﹤0.01%	5431
2023 Q1	$472	Hold	74	–	–	﹤0.01%	5488
2022 Q4	$1.12K	Hold	74	–	–	﹤0.01%	5631
2022 Q3	$0	Hold	74	–	–	﹤0.01%	5825
2022 Q2	$1K	Hold	74	–	–	﹤0.01%	5776
2022 Q1	$2K	Hold	74	–	–	﹤0.01%	5738
2021 Q4	$3K	Buy	+74	New	+$3.54K	﹤0.01%	5674

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

BlackRock's EDSA Position: Q1 2026 in Review

BlackRock opened a new position in Edesa Biotech (EDSA) in Q1 2026: 27,709 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #4872 among its holdings. This is a return to the name: BlackRock previously reported a position in EDSA as recently as Q4 2023.

BlackRock first reported a position in EDSA in Q4 2021 and has held it in 10 quarters since. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

BlackRock held 27,709 shares of Edesa Biotech worth $145K as of Q1 2026.
Edesa Biotech was a new BlackRock position in Q1 2026.
Edesa Biotech made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4872 holding.
BlackRock first reported a position in Edesa Biotech in Q4 2021 and has held it in 10 quarters since.
28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.